Literature DB >> 11562612

Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan.

J H Kao1, H M Hsu, W Y Shau, M H Chang, D S Chen.   

Abstract

OBJECTIVES: To assess the annual mortality rate associated with fulminant hepatitis in infants before and after the mass immunization program that was launched in Taiwan in July 1984. STUDY
DESIGN: From the National Mortality Registry System, the data on the mortality from fulminant hepatitis in infants from 1975 to 1998 were retrieved. Poisson regression analysis was used to assess the difference in average mortality from fulminant hepatitis in infants before (1975-1984) and after (1985-1998) the implementation of the mass hepatitis B vaccination program.
RESULTS: The ratio of yearly mortality from 1975 to 1998 was 1.10 (P <.001), representing a progressive decrease in the number of the cases. The average mortality associated with fulminant hepatitis in infants from 1975 to 1984 and from 1985 to 1998 was 5.36 and 1.71 per 100,000 infants, respectively. The ratio of the average mortality in the period from 1985 to 1998 to that in the period from 1975 to 1984 was 0.32 (P <.001).
CONCLUSIONS: These data indicate that since the institution of a program of mass hepatitis B vaccination in Taiwan, the mortality associated with fulminant hepatitis in infants has declined significantly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562612     DOI: 10.1067/mpd.2001.116277

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

1.  Concerns regarding thrombophilia testing.

Authors:  David Green
Journal:  Curr Hematol Rep       Date:  2006-03

Review 2.  Hepatitis B (prevention).

Authors:  Suzanne Norris; Abdul Mohsen
Journal:  BMJ Clin Evid       Date:  2009-09-23

3.  The effects of booster vaccination on hepatitis B vaccine in anti-HBs negative infants of HBsAg-positive mothers after primary vaccination.

Authors:  Hua Gu; Jun Yao; Wei Zhu; Huakun Lv; Suyun Cheng; Luoya Ling; Shichang Xia; Yongdi Chen
Journal:  Hum Vaccin Immunother       Date:  2013-02-19       Impact factor: 3.452

4.  Factors affecting responsiveness to hepatitis B immunization in dialysis patients.

Authors:  Ali Asan; Huriye Demirhan; Hülya Çetin Sorkun; Sevgi Özkan; Mehtap Aydın; Davut Akın; Bengü Tatar; Binali Çatak; Alper Şener; Şükran Köse
Journal:  Int Urol Nephrol       Date:  2017-06-15       Impact factor: 2.370

Review 5.  Prevention of hepatitis B.

Authors:  Mei-Hwei Chang; Ding-Shinn Chen
Journal:  Cold Spring Harb Perspect Med       Date:  2015-03-02       Impact factor: 6.915

Review 6.  Gastroenterology in developing countries: issues and advances.

Authors:  Kate L Mandeville; Justus Krabshuis; Nimzing Gwamzhi Ladep; Chris J J Mulder; Eamonn M M Quigley; Shahid A Khan
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

Review 7.  Hepatitis B virus: where do we stand and what is the next step for eradication?

Authors:  Haruki Komatsu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 8.  Prevention of liver cancer.

Authors:  Kathryn Z Guyton; Thomas W Kensler
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

9.  Safety, immunization coverage and determinants of a new kind of Hepatitis B vaccine firstly applied in Ningbo, China.

Authors:  Sijia Yang; Xiao Ma; Hongxia Ni; Shaoying Zhou; Danbiao Hu; Honghui Shi; Xiaoying Chen; Hongjun Dong; Guozhang Xu
Journal:  Hum Vaccin Immunother       Date:  2015-07-25       Impact factor: 3.452

Review 10.  Emerging hepatitis B virus infection in vaccinated populations: a rising concern?

Authors:  Tung-Hung Su; Pei-Jer Chen
Journal:  Emerg Microbes Infect       Date:  2012-09-19       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.